Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yushi Qiu
Immune Checkpoint Inhibition by Anti-Pdcd1 (Anti-Pd1) Monoclonal Antibody Has Significant Therapeutic Activity Against Central Nervous System Lymphoma in an Immunocompetent Preclinical Model
British Journal of Haematology
Hematology
Related publications
Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice
International Journal of Cancer
Cancer Research
Oncology
Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40
Cancer Research
Cancer Research
Oncology
Anti-Antibody Activity of a Monoclonal Macroglobulin
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Central Nervous System Aspergillosis in an Immunocompetent Patient
Journal of Infection in Developing Countries
Medicine
Virology
Parasitology
Infectious Diseases
Microbiology
An Adapted Anti-Ctla4 Therapeutic Aimed at Mitigating the Toxicities of Checkpoint Inhibition
Journal of Clinical Investigation
Medicine
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Cancer immunology research
Cancer Research
Immunology
Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Therapeutic Effect of Anti-Nucleokine Monoclonal Antibody on Ischemic Brain Infarction
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer
Oncotarget
Oncology
